Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2486 publications

Dual-drug-loaded magnetic lipid based nanobubbles are effective in non-small cell lung cancer treatment: in vitro and in vivo studies.

Dual-drug-loaded magnetic lipid based nanobubbles are effective in non-small cell lung cancer treatment: in vitro and in vivo studies.

Journal: Journal of liposome research
Published: October 16, 2025

Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202).

Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 03, 2025

Novel Therapeutic Approaches for Cutaneous Angiosarcoma, Particularly Focusing on Immune Checkpoint Inhibitors.

Novel Therapeutic Approaches for Cutaneous Angiosarcoma, Particularly Focusing on Immune Checkpoint Inhibitors.

Journal: Cancers
Published: September 02, 2025

Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis.

Medication-related jaw osteonecrosis in metastatic RCC treated with VEGFR-TKIs ± IO and bone agents: A real-world analysis.

Journal: Tumori
Published: August 29, 2025

From pathogenesis to the patient's bedside: a comprehensive review of extraskeletal myxoid chondrosarcoma.

From pathogenesis to the patient's bedside: a comprehensive review of extraskeletal myxoid chondrosarcoma.

Journal: Journal of cancer research and clinical oncology
Published: August 27, 2025

Evaluation of the Meet-URO Score in a Real-World Cohort of mRCC Patients Treated with First-Line TKIs.

Evaluation of the Meet-URO Score in a Real-World Cohort of mRCC Patients Treated with First-Line TKIs.

Journal: Journal of clinical medicine
Published: August 08, 2025

Potential repurposing of lapatinib and pazopanib as neuroprotective agents in a rat model of Huntington's disease.

Potential repurposing of lapatinib and pazopanib as neuroprotective agents in a rat model of Huntington's disease.

Journal: Inflammopharmacology
Published: July 29, 2025

Cost-effectiveness analysis of first-line treatment for advanced soft tissue sarcomas in China.

Cost-effectiveness analysis of first-line treatment for advanced soft tissue sarcomas in China.

Journal: Journal of medical economics
Published: July 25, 2025

Sensitive analysis of tyrosine kinase inhibitors in plasma using polypropylene fabric-solid phase extraction combined with liquid chromatography-tandem mass spectrometry.

Sensitive analysis of tyrosine kinase inhibitors in plasma using polypropylene fabric-solid phase extraction combined with liquid chromatography-tandem mass spectrometry.

Journal: Journal of chromatography. A
Published: July 17, 2025

Efficacy of intranasal delivery of VEGFR inhibitors to cervical lymph nodes for inhibiting tongue cancer metastasis in mice.

Efficacy of intranasal delivery of VEGFR inhibitors to cervical lymph nodes for inhibiting tongue cancer metastasis in mice.

Journal: Journal of drug targeting
Published: July 14, 2025

Delayed pancreatic metastasis from renal cell carcinoma managed with pazopanib and stereotactic ablative body radiotherapy.

Delayed pancreatic metastasis from renal cell carcinoma managed with pazopanib and stereotactic ablative body radiotherapy.

Journal: Journal of surgical case reports
Published: July 12, 2025

Metabolic heterogeneity and survival outcomes in papillary renal cell carcinoma: insights from multi-datasets and machine learning analyses.

Metabolic heterogeneity and survival outcomes in papillary renal cell carcinoma: insights from multi-datasets and machine learning analyses.

Journal: Hereditas
Published: July 10, 2025
Showing 1-12 of 2,486

Last Updated: 10/31/2025